Last update 26 Oct 2025

FS-8002

Overview

Basic Info

Drug Type
Antibody fusion proteins
Synonyms
FS-8002, JS214
Target
TGF-β x VEGF
Action
inhibitors
Mechanism
TGF-β inhibitors(Transforming growth factor beta inhibitors), VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmNeoplasms
Inactive Indication-
Originator Organization
Changchun Huapu Biotechnology Co. Ltd.Changchun Huapu Biotechnology Co. Ltd.
Active Organization
Shanghai Pushi Medical Science Co. LtdFusion Biosciences Pty Ltd.Fushengkang (Shanghai) Biotechnology Co., Ltd.
+ [1]
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FS-8002
NCT06832982
/ RecruitingPhase 1
A Single-arm, Open Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 in Patients With Advanced Solid Tumors
100 Clinical Results associated with FS-8002
Login to view more data
100 Translational Medicine associated with FS-8002
Login to view more data
100 Patents (Medical) associated with FS-8002
Login to view more data
100 Deals associated with FS-8002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Shanghai Pushi Medical Science Co. Ltd
13 Feb 2025
Advanced Malignant Solid NeoplasmPhase 1
China
Changchun Huapu Biotechnology Co. Ltd.Changchun Huapu Biotechnology Co. Ltd.
13 Feb 2025
Advanced Malignant Solid NeoplasmPhase 1
China
Fushengkang (Shanghai) Biotechnology Co., Ltd.
13 Feb 2025
NeoplasmsPreclinical
China
Fusion Biosciences Pty Ltd.
28 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free